Cogan's Syndrome (CS) is a rare autoimmune disorder that primarily affects the eyes and ears, leading to symptoms such as interstitial keratitis (inflammation of the cornea) and sensorineural ...

Exclusion criteria included history of or ongoing interstitial lung disease or ... dry eye, vomiting, keratitis, and increased alanine aminotransferase, aspartate aminotransferase and alkaline ...

In the DATROWAY arm, the interstitial lung disease (ILD ... DATROWAY can cause ocular adverse reactions including dry eye, keratitis, blepharitis, meibomian gland dysfunction, increased ...

January's FDA oncology approvals offer new treatment options for breast cancer, mantle cell lymphoma, and other malignancies.

Neurotrophic keratitis is historically a rare disease, but now that more understanding has been gained of the underlying etiology and manifestations, its prevalence is starting to increase ...

Interstitial cystitis (IC) and overactive bladder (OAB) are two distinct but related conditions that affect the bladder and can significantly affect quality of life. IC is also referred to as ...

It absorbs shocks to our systems. Its interstitial fluid is a critical part of dispatching white blood cells, the community organizers of our biology, to fight infections. It is core to our existence.

This guidance represents the view of NICE, arrived at after careful consideration of the evidence available. When exercising their judgement, healthcare professionals are expected to take this ...

The term scleritis describes a chronic inflammation that involves the outermost coat and skeleton of the eye. Disease can be isolated to the eye, but in up to half of affected individuals it ...

Also backs Ofev as first drug for rare lung disease Meanwhile, NICE has also recommended Boehringer Ingelheim's Ofev (nintedanib) for adult patients with chronic fibrosing interstitial lung ...

particularly interstitial lung disease (ILD). Last year, the combination of Tukysa with Roche's rival HER2-directed ADC Kadcyla (trastuzumab emtansine) showed efficacy in the HER2CLIMB-02 study as ...

“Colorectal cancer is the third leading cause of cancer-related deaths in the United States, and fewer than one in five people diagnosed with metastatic disease survive beyond five years after ...